{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "17112694", "DateCompleted": {"Year": "2007", "Month": "06", "Day": "13"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"ArticleDate": [{"Year": "2006", "Month": "10", "Day": "20"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0378-8741", "JournalIssue": {"Volume": "110", "Issue": "3", "PubDate": {"Year": "2007", "Month": "Apr", "Day": "04"}}, "Title": "Journal of ethnopharmacology", "ISOAbbreviation": "J Ethnopharmacol"}, "ArticleTitle": "Phenolic-rich fraction from Rhus verniciflua Stokes (RVS) suppress inflammatory response via NF-kappaB and JNK pathway in lipopolysaccharide-induced RAW 264.7 macrophages.", "Pagination": {"StartPage": "490", "EndPage": "497", "MedlinePgn": "490-7"}, "Abstract": {"AbstractText": ["The effects of phenolic-rich fraction (PRF) from Rhus verniciflua Stokes (Anacardiaceae) on the activities of cellular signaling molecules that mediate inflammatory responses in LPS-induced RAW 264.7 macrophages were investigated. At various concentrations of PRF significantly inhibited NO, PGE(2) and TNF-alpha production in LPS-induced RAW 264.7 macrophage cells. The PRF also significantly inhibited iNOS and COX-2 protein expression in LPS-induced RAW 264.7 macrophage in a concentration-dependent manner. Transcription factor NF-kappaB plays a key role for the inducible expression of genes mediating proinflammatory effects and here, we show that PRF can inhibit the induction of NF-kappaB activity. The PRF effectively inhibited the iNOS and COX-2 protein expression through suppression of phospho-JNK1/2 activation. Study using PDA HPLC has found that the PRF contains several low molecular compounds (i.e. p-coumaric acid, fustin, kaempferol-3-O-glucoside, sulfuretin, butein, kaempferol). Our results indicate that the anti-inflammatory properties of PRF might result from the inhibition of pro-inflammatory mediators (e.g., NO, PGE(2) and TNF-alpha) by suppression of such signaling pathways as NF-kappaB and JNK1/2."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Clinical Biology and Pharmacogenomics, College of Oriental Medicine, Kyunghee University, Seoul 130-701, Republic of Korea."}], "Identifier": [], "LastName": "Jung", "ForeName": "Chang Hwa", "Initials": "CH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "Ji Hye", "Initials": "JH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hong", "ForeName": "Myung Hee", "Initials": "MH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Seog", "ForeName": "Ho Moon", "Initials": "HM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Oh", "ForeName": "Seong Hoon", "Initials": "SH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lee", "ForeName": "Pan Jae", "Initials": "PJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "Gyung Jun", "Initials": "GJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "Hyung Min", "Initials": "HM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Um", "ForeName": "Jae Young", "Initials": "JY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ko", "ForeName": "Seong-Gyu", "Initials": "SG"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "J Ethnopharmacol", "NlmUniqueID": "7903310", "ISSNLinking": "0378-8741"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipopolysaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenols"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type II"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Cyclooxygenase 2"}, {"RegistryNumber": "EC 2.7.11.24", "NameOfSubstance": "JNK Mitogen-Activated Protein Kinases"}, {"RegistryNumber": "K7Q1JQR04M", "NameOfSubstance": "Dinoprostone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage", "chemistry", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": [], "DescriptorName": "Cell Survival"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cyclooxygenase 2"}, {"QualifierName": ["metabolism"], "DescriptorName": "Dinoprostone"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "JNK Mitogen-Activated Protein Kinases"}, {"QualifierName": [], "DescriptorName": "Lipopolysaccharides"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Macrophages"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["drug effects"], "DescriptorName": "Nitric Oxide Synthase Type II"}, {"QualifierName": ["administration & dosage", "isolation & purification", "pharmacology"], "DescriptorName": "Phenols"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plant Bark"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Rhus"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Tumor Necrosis Factor-alpha"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2006", "Month": "6", "Day": "19"}, {"Year": "2006", "Month": "10", "Day": "11"}, {"Year": "2006", "Month": "10", "Day": "12"}, {"Year": "2006", "Month": "11", "Day": "23", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "6", "Day": "15", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "11", "Day": "23", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17112694", "10.1016/j.jep.2006.10.013", "S0378-8741(06)00528-9"]}}], "PubmedBookArticle": []}